Open Access Study protocol

A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial

Anne Katrin Berger*, Carl von Gall, Ulrich Abel, Stefan Delorme, Matthias Kloor, Jennifer Ose, Tim Frederik Weber, Annika Stange, Georg Martin Haag, Uwe Haberkorn, Florian Lordick and Dirk Jäger

BMC Cancer 2012, 12:108  doi:10.1186/1471-2407-12-108

Article Metrics

Total accesses

Article metric FAQ


  • Last 30 days: 26 accesses
  • Last 365 days: 430 accesses
  • All time: 2163 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information